Dupixent
FDA Expands Dupilumab EoE Indication to Children as Young as 1 Year
The FDA expanded the indications for dupilumab (Dupixent, Regeneron/Sanofi) to include treatment of children with ...
JANUARY 26, 2024
Exploring Use of Dupilumab for Patients With EoE
The clinical trial data supporting dupilumab for the treatment of eosinophilic esophagitis were very strong in the ...
JULY 29, 2022
Load more